Skip to main content

Table 2 Effect of bitter melon and glibenclamide on clinical/metabolic variables of study groups

From: Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients

Variables

Baseline

Endpoint (week 10)

FPG (mg/dl)

Bitter melon 2 g/day (Group I)

146±13.40

133.70±11.50*

Bitter melon 4 g/day (Group II)

141.60±15.20

126.40±11.90*

Glibenclamide 5 mg/day (Group III)

143.50±18.40

117±10.30¤

2 h post OGTT plasma glucose (mg/dl)

Bitter melon 2 g/day (Group I)

241.30±15.60

235±19.50

Bitter melon 4 g/day (Group II)

247±21.90

240.70±25.10

Glibenclamide 5 mg/day (Group III)

255.60±26.30

229.40±20.80*

T C (mg/dl)

Bitter melon 2 g/day (Group I)

218.25±10.70

214.50±14.50

Bitter melon 4 g/day (Group II)

227.10±15.50

221±11.60

Glibenclamide 5 mg/day (Group III)

220.50±11.10

222±10.80

LDL-c (mg/dl)

Bitter melon 2 g/day (Group I)

149.70±18.20

146.50±11.50

Bitter melon 4 g/day (Group II)

154±15.50

148.90±16.40

Glibenclamide 5 mg/day (Group III)

146.80±10.30

148.50±12.35

HDL-c (mg/dl)

Bitter melon 2 g/day (Group I)

48.15±4.90

50±3.50

Bitter melon 4 g/day (Group II)

47.60±5.70

51.20±4.20

Glibenclamide 5 mg/day (Group III)

48.10±5.50

45±4.90

T G (mg/dl)

Bitter melon 2 g/day (Group I)

163.20±17.50

159.80±16.70

Bitter melon 4 g/day (Group II)

168±13.40

154.20±11.80*

Glibenclamide 5 mg/day (Group III)

165.50±20.50

172.90±18.40

T C/HDL-c ratio

Bitter melon 2 g/day (Group I)

4.53±1.10

4.29±1.20

Bitter melon 4 g/day (Group II)

4.77±1.60

4.31±1.35

Glibenclamide 5 mg/day (Group III)

4.58±1.15

4.93±1.50

LDL-c/HDL-c ratio

Bitter melon 2 g/day (Group I)

3.10±1.35

2.93±1.10

Bitter melon 4 g/day (Group II)

3.23±1.52

2.89±1.31

Glibenclamide 5 mg/day (Group III)

3±1.47

3.30±1.20

SBP (mmHg)

Bitter melon 2 g/day (Group I)

139±8.10

135.50±11.90

Bitter melon 4 g/day (Group II)

144.80±23.70

133.10±14.30*

Glibenclamide 5 mg/day (Group III

136.20±12.24

135.50±10.50

Weight (Kg)

Bitter melon 2 g/day (Group I)

69.50±10.70

67.65±11.32

Bitter melon 4 g/day (Group II)

73.90±12.20

70.80±10.50

Glibenclamide 5 mg/day (Group III

68.40±8.30

70±11.90

  1. *p≤0.05 compared to baseline; ¤p≤0.01 compared to baseline; p≤0.05 compared to group III at week 10.